Upregulation of HIF-1α within the tumor can lead to decreased expression of the natural killer group 2 member D (NKG2D) receptor on NK and T cells, leading to immune evasion and impaired tumor cell killing [101,102]. This evidence concerns the gene HIF1A and neoplasm.